Updated Hepatitis D Seroprevalence Among Hepatitis B Surface Antigen-Positive Persons Aged ≥6 Years in the United States, National Health and Nutrition Examination Survey, 2007‒2018
- 25 April 2026
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (3) , e530-e532
Abstract
To validate the accuracy of previously published US seroprevalence estimates for hepatitis D virus (HDV) antibody, we retested National Health and Nutrition Examination Survey samples from 2007 to 2018 using a different assay. We found the HDV seroprevalence among hepatitis B surface antigen-positive participants aged ≥6 years to be 1.26%.Keywords
Funding Information
- Centers for Disease Control and Prevention
- U.S. Department of Health and Human Services
This publication has 12 references indexed in Scilit:
- Prevalence of Hepatitis D in the United StatesThe Journal of Applied Laboratory Medicine, 2025
- A call to reclassify the delta hepatitis virus as an orphan diseaseHepatology Communications, 2025
- Epidemiological Burden of Hepatitis Delta Virus in the United StatesJournal of Viral Hepatitis, 2025
- Hepatitis DJAMA, 2023
- The global prevalence of hepatitis D virus infection: Systematic review and meta-analysisJournal of Hepatology, 2020
- Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studiesJournal of Hepatology, 2020
- Hepatitis Delta Estimates in the United States RevisitedClinical Infectious Diseases, 2019
- Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011–2016Clinical Infectious Diseases, 2019
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidanceHepatology, 2018
- A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus–infected mongoliansHepatology, 2016